China · Delayed Price · Currency is CNY Zhejiang Haisen Pharmaceutical Company Description
Zhejiang Haisen Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical intermediates, active pharmaceutical ingredients, and preparations in China and internationally.
The company offers active pharmaceutical ingredients for use as antilipemic agents, antipyretic analgesics, antidepressants, analgesics, antibacterial agents, histamine drugs, and anticonvulsants, as well as for anti-gastric ulcers, and digestive and cardiovascular applications.
It also provides chemical products for use as paroxetine HCl and amikacin sulphate intermediates and food additives; and escitalopram oxalate tablets to treat depression and panic disorders under the Tezi brand.
In addition, the company engages in the import and export of goods; trading; and medical research and experimental development activities.
Zhejiang Haisen Pharmaceutical Co., Ltd. was incorporated in 1998 and is headquartered in Dongyang, China.
| Country | China |
| Founded | 1998 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 705 |
| CEO | Lin Ai |
Contact Details
Address: Xiangtan Village Dongyang, 322104 China | |
| Phone | 86 579 8677 3082 |
| Website | haisenpharma.com |
Stock Details
| Ticker Symbol | 001367 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Lin Ai | GM and Director |
| Aijuan Pan | Chief Financial Officer |
| Kangkang Hu | Company Secretary |
| Sheng-Quan Zhang | Deputy General Manager |
| Yanjun Lou | Deputy General Manager |